FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Dr. rer. nat. Simon Völkl
List of publications:
BibTeX-Download
Department of Medicine 5 – Haematology and Oncology
Project Leads
(1)
Publications
(90)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies (2024)
Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kleyer A, Gary R, et al.
Journal article, Letter
BCL10 Deficiency Presenting as Severe Combined Immunodeficiency Escaping Newborn Screening (2024)
Salou S, Völkl S, Keller B, Ehl S, Naumann-Bartsch N
Journal article
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up. (2024)
Müller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, Völkl S, Aigner M, et al.
Journal article
Increased PD-1 Expression on Circulating T Cells Correlates with Inferior Outcome after Autologous Stem Cell Transplantation (2024)
Richter S, Böttcher M, Stoll A, Zeremski V, Völkl S, Mackensen A, Ekici AB, et al.
Journal article
Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy (2023)
Nunez D, Patel D, Volkov J, Wong S, Vorndran Z, Müller F, Aigner M, et al.
Journal article
Identification and characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains (2023)
Reimann H, Moosmann C, Schober K, Lang V, Verhagen J, Zeun J, Mackensen A, et al.
Journal article
Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy (2023)
Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Jacobs B, Eisenhauer N, et al.
Journal article, Letter
Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT (2023)
Karl F, Liang C, Böttcher-Loschinski R, Stoll A, Flamann C, Richter S, Lischer C, et al.
Journal article
CD19-targeted CAR T cells in refractory antisynthetase syndrome (2023)
Müller F, Böltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, et al.
Journal article
Accumulation of T-cell-suppressive PD-L1 high extracellular vesicles is associated with GvHD and might impact GvL efficacy (2023)
Baur R, Karl F, Böttcher-Loschinski R, Stoll A, Völkl S, Gießl A, Flamann C, et al.
Journal article
‹
1
2
3
...
9
›